TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionAllworth Financial LP
Latest Disclosed Ownership1,162 shares
Latest Disclosed Value $ 38,602
Allworth Financial LP reports 94.31% increase in ownership of 1TGTX / TG Therapeutics, Inc.

On May 14, 2026 - Allworth Financial LP filed a 13F-HR form disclosing ownership of 1,162 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $32,141 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 598 shares of TG Therapeutics, Inc.. This represents a change in shares of 94.31% during the quarter. The current value of the position is $39,508 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 1,162 564 94.31 39 123.53 0.0002
2026-02-05 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 598 31 5.47 18 -15.00 0.0001
2025-12-02 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 567 -65 -10.28 20 -9.09 0.0001
2025-08-07 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 632 23 3.78 23 -8.33 0.0001
2025-04-30 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 609 -149 -19.66 25 9.09 0.0001
2025-01-30 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 758 21 2.85 22 29.41 0.0001
2024-10-23 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 737 12 1.66 17 13.33 0.0001
2024-07-24 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 725 0 0.00 15 36.36 0.0001
2024-04-25 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 725 -225 -23.68 11 -31.25 0.0001
2024-01-24 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 950 -13 -1.35 16 100.00 0.0001
2023-10-31 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 963 13 1.37 8 -65.22 0.0001
2023-07-18 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 950 0 0.00 24 64.29 0.0002
2023-04-18 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 950 850 850.00 14 1,300.00 0.0001
2023-01-13 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 100 0 0.00 1 0.00 0.0000
2022-11-14 2022-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 100 100 1 0.0000
2022-10-18 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 100 100 1 0.0000
2019-05-07 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -62 -100.00 0 0.0000
2019-02-11 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 0 0.0000
2018-10-29 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 0 -100.00
2018-08-08 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.00 0.0000
2018-05-01 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.00 0.0001
2018-02-21 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.00 0.0001
2017-10-12 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.00 0.0001
2017-08-07 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.00 0.0001
2017-05-09 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 1 0.0001
2017-02-02 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 0 0.0000
2017-02-07 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 62 0 0.00 0 0.0000
2016-08-22 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 62 62 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.